Innosphere

Company Overview

Snapshot

Founded in May 2016 by Rami Shacour, Ehab Shakour, Gabriel Shakour, and Yousef Badran, Innosphere is a medical device company with 1–10 employees. The company has raised $2.5 million across two funding rounds. Innosphere is developing an AI-based brain stimulation device for the treatment of ADHD, currently undergoing clinical trials at Hadassah Medical Center in Jerusalem and King's College of London.

Business overview

Innosphere is a medical device company focused on developing brain stimulation treatments for cognitive disorders, specifically ADHD. The company's core technology involves a wearable device that utilizes AF-RNS technology and a unique AI algorithm to personalize treatment protocols, aiming to optimize efficacy for each patient. Innosphere serves the healthcare market, targeting both B2C and B2B segments, and operates within the Health Tech & Life Sciences sector, particularly in Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In June 2019, news highlighted high hopes for Innosphere's new ADHD treatment device. This signals potential validation for the company's innovative approach to cognitive disorder treatment, suggesting a positive outlook for its wearable brain stimulation technology and its ongoing clinical trials.

Company Intelligence Q&A

What is Innosphere's primary focus?

Innosphere is a medical device company developing AI-based brain stimulation treatments for cognitive disorders, with a primary focus on ADHD.

When was Innosphere founded and by whom?

Innosphere was founded in May 2016 by Rami Shacour, Ehab Shakour, Gabriel Shakour, and Yousef Badran.

What is Innosphere's core technology?

Innosphere's core technology is a wearable device that uses AF-RNS technology and a unique AI algorithm to personalize brain stimulation treatment protocols for patients.

Where are Innosphere's clinical trials being conducted?

Innosphere is conducting clinical trials at Hadassah Medical Center in Jerusalem and King's College of London to alleviate ADHD symptoms using its patented technologies in collaboration with Yale University and the University of Oxford.

What was a notable development for Innosphere in July 2022?

In July 2022, Innosphere secured a grant from the BIRD Foundation.